Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines

被引:69
作者
Hillaire, Marine L. B. [1 ]
Osterhaus, Albert D. M. E. [1 ,2 ]
Rimmelzwaan, Guus F. [1 ,2 ]
机构
[1] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands
[2] Viroclin Biosci BV, NL-3016 BC Rotterdam, Netherlands
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2011年
关键词
VIROSOME-MEDIATED DELIVERY; RESPONSE IN-VITRO; A-VIRUS; HETEROSUBTYPIC IMMUNITY; CELL RESPONSES; H5N1; INFLUENZA; DNA VACCINES; ADENOVIRUS VECTORS; LETHAL INFECTION; DENDRITIC CELLS;
D O I
10.1155/2011/939860
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is considerable interest in the development of broadly protective influenza vaccines because of the continuous emergence of antigenic drift variants of seasonal influenza viruses and the threat posed by the emergence of antigenically distinct pandemic influenza viruses. It has been recognized more than three decades ago that influenza A virus-specific cytotoxic T lymphocytes recognize epitopes located in the relatively conserved proteins like the nucleoprotein and that they cross-react with various subtypes of influenza A viruses. This implies that these CD8(+) T lymphocytes may contribute to protective heterosubtypic immunity induced by antecedent influenza A virus infections. In the present paper, we review the evidence for the role of virus-specific CD8(+) T lymphocytes in protective immunity against influenza virus infections and discuss vaccination strategies that aim at the induction of cross-reactive virus-specific T-cell responses.
引用
收藏
页数:12
相关论文
共 158 条
[1]   Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective [J].
Abelin, Atika ;
Colegate, Tony ;
Gardner, Stephen ;
Hehme, Norbert ;
Palache, Abraham .
VACCINE, 2011, 29 (06) :1135-1138
[2]  
[Anonymous], FOOD DRUG ADM GUID I
[3]  
[Anonymous], 1997, NOT GUID HARM REQ IN
[4]   CYTO-TOXIC T-CELLS IN INFLUENZA INFECTION [J].
ASKONAS, BA ;
TAYLOR, PM ;
ESQUIVEL, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 532 :230-237
[5]   Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge [J].
Barefoot, Brice E. ;
Athearn, Kathleen ;
Sample, Christopher J. ;
Ramsburg, Elizabeth A. .
VACCINE, 2009, 28 (01) :79-89
[6]   Recombinant Vesicular Stomatitis Virus Expressing Influenza Nucleoprotein Induces CD8 T-Cell Responses That Enhance Antibody-Mediated Protection after Lethal Challenge with Influenza Virus [J].
Barefoot, Brice E. ;
Sample, Christopher J. ;
Ramsburg, Elizabeth A. .
CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (04) :488-498
[7]   Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin [J].
Basha, Saleem ;
Hazenfeld, Staci ;
Brady, Rebecca C. ;
Subbramanian, Ramu A. .
HUMAN IMMUNOLOGY, 2011, 72 (06) :463-469
[8]   Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses [J].
Belz, GT ;
Stevenson, PG ;
Doherty, PC .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2404-2409
[9]   A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge [J].
Belz, GT ;
Xie, WD ;
Altman, JD ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3486-3493
[10]   Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells [J].
Benton, KA ;
Misplon, JA ;
Lo, CY ;
Brutkiewicz, RR ;
Prasad, SA ;
Epstein, SL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7437-7445